The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Self-citationBrowder, T. D., Butterfield, C., Kräling, B. M., Shi, B., Marshall, B., OʼReilly, M., & Folkman, J. (2000) · PubMed · Cited by 1,543
Self-citationAntiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
The anti-angiogenic basis of metronomic chemotherapy
Kerbel, R. S., & Kamen, B. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1369 · Cited by 1,397
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988 · cited 1×
“Rat carcinogen induced mammary cancer [42] Pancreatic insulinoma [107]”
BackgroundSelf-citationNovel antiangiogenic effects of the bisphosphonate compound zoledronic acid.
Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035295 · Cited by 854
Relf, M., LeJeune, S., Scott, P. A. E., Fox, S. B., Smith, K. A., Leek, R., Moghaddam, A., Whitehouse, R. M., Bicknell, R., & Harris, A. L. (1997) · PubMed · Cited by 833
Endogenous Inhibitors of Angiogenesis
Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 553
Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., & Kalluri, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730882100 · Cited by 488
Sunwoo, J. B., Chen, Z., Dong, G., Yeh, N. T., Bancroft, C. C., Sausville, E. A., Adams, J., Elliott, P. J., & Waes, C. V. (2001) · PubMed · Cited by 473
Secreted cathepsin L generates endostatin from collagen XVIII
Felbor, U. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1187 · Cited by 469
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
Rastinejad, F., Polverini, P. J., & Bouck, N. P. (1989) · Cell · doi:10.1016/0092-8674(89)90238-9 · Cited by 463
Yamaguchi, N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4414 · Cited by 444
Endostatin's Antiangiogenic Signaling Network
Abdollahi, A., Hahnfeldt, P., Maercker, C., Gröne, H.-J., Debus, J., Ansorge, W., Folkman, J., Hlatky, L., & Huber, P. E. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00102-9 · Cited by 393
Self-citationContinuous release of endostatin from microencapsulated engineered cells for tumor therapy
Joki, T., Machluf, M., Atala, A., Zhu, J., Seyfried, N. T., Dunn, I. F., Abe, T., Carroll, R. S., & Black, P. M. (2001) · Nature Biotechnology · doi:10.1038/83481 · Cited by 365
Eggert, A., Ikegaki, N., Kwiatkowski, J. L., Zhao, H., Brodeur, G. M., & Himelstein, B. P. (2000) · PubMed · Cited by 353
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
Satchi-Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345
Self-citationEndogenous angiogenesis inhibitors
FOLKMAN, J. (2004) · APMIS · doi:10.1111/j.1600-0463.2004.apm11207-0809.x · Cited by 321
Self-citationThe generation of endostatin is mediated by elastase.
Wen, W. X., Moses, M. A., Wiederschain, D., Arbiser, J. L., & Folkman, J. (1999) · PubMed · Cited by 318
Self-citationKisker, O., Becker, C. M., Prox, D., Fannon, M. W., D’Amato, R. J., Flynn, E. A., Fogler, W. E., Sim, B. K. L., Allred, E. N., Pirie-Shepherd, S. R., et al. (2001) · PubMed · Cited by 283
Self-citationPPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis
Panigrahy, D., Singer, S., Shen, L. Q., Butterfield, C. E., Freedman, D. A., Chen, E. J., Moses, M. A., Kilroy, S., Duensing, S., Fletcher, C., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215634 · Cited by 276
Self-citationKuo, C. J., Farnebo, F., Yu, E. Y., Christofferson, R., Swearingen, R. A., Carter, R., von Recum, H. A., Yuan, J., Kamihara, J., Flynn, E., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081615298 · Cited by 271
Self-citationAntiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2a
Kaban, L. B., Mulliken, J. B., Ezekowitz, R. A., Phil, D., Ebb, D., Smith, P. S., & Folkman, J. (1999) · Pediatrics · doi:10.1542/peds.103.6.1145 · Cited by 245
Self-citationEndostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
Dhanabal, M., Ramchandran, R., Volk, R., Stillman, I. E., Lombardo, M., Iruela‐Arispe, M. L., Simons, M., & Sukhatme, V. P. (1999) · PubMed · Cited by 240
Sauter, B. V., Martinet, O., Zhang, W.-J., Mandeli, J., & Woo, S. L. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090065597 · Cited by 229
Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor Growth
O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Cao, Y., Moses, M., Lane, W. S., Sage, E. H., & Folkman, J. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.052 · Cited by 216
Self-citationAntiangiogenesis signals by endostatin
SHICHIRI, M., & HIRATA, Y. (2001) · The FASEB Journal · doi:10.1096/fj.99-1083com · Cited by 208
Wickström, S. A., Alitalo, K. K., & Keski‐Oja, J. (2002) · PubMed · Cited by 207
Oh, S. P., Kamagata, Y., Muragaki, Y., Timmons, S., Ooshima, A., & Olsen, B. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4229 · Cited by 187
Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
Sund, M., Hamano, Y., Sugimoto, H., Sudhakar, A., Soubasakos, M., Yerramalla, U., Benjamin, L. E., Lawler, J., Kieran, M., Shah, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500180102 · Cited by 179
Abdollahi, A., Lipson, K. E., Sckell, A., Zieher, H., Klenke, F. M., Poerschke, D., Roth, A. K., Han, X., Krix, M., Bischof, M., et al. (2003) · PubMed · Cited by 178
Angiomotin Regulates Endothelial Cell-Cell Junctions and Cell Motility
Bratt, A., Birot, O., Sinha, I., Veitonmäki, N., Aase, K., Ernkvist, M., & Holmgren, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503915200 · Cited by 175
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin
Satchi-Fainaro, R., Mamluk, R., Wang, L., Short, S. M., Nagy, J. A., Feng, D., Dvorak, A. M., Dvorak, H. F., Puder, M., Mukhopadhyay, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.007 · Cited by 173
Self-citationNyberg, P., Heikkilä, P., Sorsa, T., Luostarinen, J., Heljasvaara, R., Stenman, U.-H., Pihlajaniemi, T., & Salo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210325200 · Cited by 166
Mouse endostatin inhibits the formation of lung and liver metastases.
Yoon, S. S., Eto, H., Lin, C., Nakamura, H., Pawlik, T. M., Song, S. U., & Tanabe, K. K. (1999) · PubMed · Cited by 160
Zorick, T. S., Mustacchi, Z., Bando, S. Y., Zatz, M., Moreira‐Filho, C. A., Olsen, B. R., & Passos‐Bueno, M. R. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200721 · Cited by 150
Ma, L., Soldato, P. D., & Wallace, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202392199 · Cited by 139
Zinc-dependent dimers observed in crystals of human endostatin
Ding, Y., Javaherian, K., Lo, K.-M., Chopra, R., Boehm, T., Lanciotti, J., Harris, B. A., Li, Y., Shapiro, R., Hohenester, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10443 · Cited by 135
Self-citationTherapeutic Efficacy of Endostatin Exhibits a Biphasic Dose-Response Curve
Celik, I., Sürücü, O., Dietz, C., Heymach, J. V., Force, J. M., Höschele, I., Becker, C. M., Folkman, J., & Kisker, O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2617 · Cited by 134
Self-citationEndostatin: The logic of antiangiogenic therapy
Abdollahi, A., Hlatky, L., & Huber, P. E. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.03.001 · Cited by 131
Ohlfest, J. R., Demorest, Z. L., Motooka, Y., Vengco, I., Oh, S., Chen, E. Y., Scappaticci, F. A., Saplis, R., Ekker, S. C., Low, W. C., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.689 · Cited by 130
Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated
Wahl, M., Kenan, D. J., Gonzalez–Gronow, M., & Pizzo, S. V. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20480 · Cited by 125
Capillo, M., Mancuso, P., Gobbi, A., Monestiroli, S., Pruneri, G., Dell’Agnola, C., Martinelli, G., Shultz, L. D., & Bertolini, F. (2003) · PubMed · Cited by 123
Feldman, A. L., Restifo, N. P., Alexander, H. R., Bartlett, D. L., Hwu, P., Seth, P. K., & Libutti, S. K. (2000) · PubMed · Cited by 118
Wickström, S. A., Alitalo, K. K., & Keski‐Oja, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312921200 · Cited by 117
Scappaticci, F. A., Smith, R., Pathak, A., Schloss, D. J., Lum, B. L., Cao, Y., Johnson, F. L., Engleman, E. G., & Nolan, G. P. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0243 · Cited by 114
Zinc-Binding of Endostatin Is Essential for Its Antiangiogenic Activity
Boehm, T., O’Reilly, M. S., Keough, K. C., Shiloach, J., Shapiro, R., & Folkman, J. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9617 · Cited by 114
Self-citationSjin, R. M. T. T., Satchi‐Fainaro, R., Birsner, A. E., Ramanujam, V. M. S., Folkman, J., & Javaherian, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1833 · Cited by 106
Self-citationAntitumor activity of endostatin against carcinogen-induced rat primary mammary tumors.
Perletti, G., Concari, P., Giardini, R., Marras, E., Piccinini, F., Folkman, J., & Chen, L. (2000) · PubMed · Cited by 93
Self-citationEndostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models
Lee, C., Wu, C., & Shiau, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.626 · Cited by 93
Fu, G., Li, X., Hou, Y., Fan, Y., Liu, W., & Xu, G. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700758 · Cited by 91
Effect of Antiangiogenic Therapy on Slowly Growing, Poorly Vascularized Tumors in Mice
Beecken, W.-D., Fernandez, A., Joussen, A. M., Achilles, E. G., Flynn, E., Lo, K.-M., Gillies, S. D., Javaherian, K., Folkman, J., & Shing, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.382 · Cited by 89
Self-citationChen, C. T., Lin, J., Li, Q., Phipps, S. S., Jakubczak, J. L., Stewart, D. A., Skripchenko, Y., Forry‐Schaudies, S., Wood, J. M., Schnell, C., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050143417 · Cited by 88
Bertolini, F., Fusetti, L., Mancuso, P., Gobbi, A., Corsini, C. A., Ferrucci, P. F., Martinelli, G., & Pruneri, G. (2000) · Blood · doi:10.1182/blood.v96.1.282 · Cited by 87
E-selectin is required for the antiangiogenic activity of endostatin
Yu, Y., Moulton, K. S., Khan, M. K., Vineberg, S., Boye, E., DAVIS, V. M., O’Donnell, P., Bischoff, J. E., & Milstone, D. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402551101 · Cited by 84
Skovseth, D. K., Veuger, M. J. T., Sørensen, D. R., Angelis, P. M. D., & Haraldsen, G. (2004) · Blood · doi:10.1182/blood-2004-03-1164 · Cited by 79
Ding, I., Sun, J., Fenton, B. M., Liu, W. M., Kimsely, P., Okunieff, P. G., & Min, W. (2001) · PubMed · Cited by 77
Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy
Ponnazhagan, S., Mahendra, G., Kumar, S., Shaw, D. R., Stockard, C. R., Grizzle, W. E., & Meleth, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1786 · Cited by 72
Velde, E. A. T., Vogten, J. M., Gebbink, M. F. B. G., van Gorp, J. M., Voest, E. E., & Rinkes, I. H. M. B. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.02183.x · Cited by 71
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli, L., Donnini, S., Chillemi, F., Giachetti, A., & Ziche, M. (2003) · PubMed · Cited by 71
Sim, B. K. L., Fogler, W. E., Zhou, X. H., Liang, H., Madsen, J. W., Luu, K., O’Reilly, M. S., Tomaszewski, J. E., & Fortier, A. H. (1999) · Angiogenesis · doi:10.1023/a:1009058931769 · Cited by 66
Huang, X., Wong, M. K., Zhao, Q., Zhu, Z., Wang, K.-Z., Huang, N., Ye, C., Gorelik, E., & Li, M. (2001) · PubMed · Cited by 63
Pulmonary Capillary Hemangiomatosis With Atypical Endotheliomatosis *
Ginns, L. C., Roberts, D. H., Mark, E. J., Brusch, J. L., & Marler, J. J. (2003) · CHEST Journal · doi:10.1378/chest.124.5.2017 · Cited by 62
Schmidt, N. O., Ziu, M., Carrabba, G. G., Giussani, C. G., Bello, L., Sun, Y., Schmidt, K. F., Albert, M., Black, P. M., & Carroll, R. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0052 · Cited by 60
Eisterer, W., Jiang, X., Bachelot, T., Pawliuk, R., Abramovich, C., Leboulch, P., Hogge, D. E., & Eaves, C. J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0573 · Cited by 57
Gene therapy delivery of endostatin enhances the treatment efficacy of radiation
Shi, W., Teschendorf, C., Muzyczka, N., & Siemann, D. W. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(02)00280-3 · Cited by 56
Antiangiogenic activity of endostatin inhibits c6 glioma growth
Peroulis, I., Jonas, N., & Saleh, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.10115 · Cited by 55
Continuous Intravascular Secretion of Endostatin in Mice from Transduced Hematopoietic Stem Cells
Pawliuk, R., Bachelot, T., Zurkiya, O., Eriksson, A., Cao, Y., & Leboulch, P. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0572 · Cited by 54
Dutour, A., Monteil, J., Paraf, F., Charissoux, J. L., Kaletta, C., Sauer, B., Naujoks, K., & Rigaud, M. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.10.008 · Cited by 54
Barnett, F. H., Scharer-Schuksz, M., Wood, M., Yu, X. L., Wagner, T. E., & Friedlander, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302287 · Cited by 50
Shi, W., Teschendorf, C., Muzyczka, N., & Siemann, D. W. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700463 · Cited by 50
Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma
Sørensen, D. R., Read, T., Porwol, T., Olsen, B. R., Timpl, R., Sasaki, T., Iversen, P. O., Benestad, H. B., Sim, B. K. L., & Bjerkvig, R. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.1.1 · Cited by 50
Noro, T., Miyake, K., Suzuki-Miyake, N., Igarashi, T., Uchida, E., Misawa, T., Yamazaki, Y., & Shimada, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1296 · Cited by 47
Calvo, A., Yokoyama, Y., Smith, L. E. H., Ali, I., Shih, S., Feldman, A. L., Libutti, S. K., Sundaram, R., & Green, J. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10589 · Cited by 47
Combined endostatin/sFlt‐1 antiangiogenic gene therapy is highly effective in a rat model of HCC†
Graepler, F., Verbeek, B., Graeter, T., Smirnow, I., Kong, H. L., Schuppan, D., Bauer, M. W., Vonthein, R., Gregor, M., & Lauer, U. M. (2005) · Hepatology · doi:10.1002/hep.20613 · Cited by 46
Iversen, P., Sørensen, D., & Benestad, H. B. (2002) · Leukemia · doi:10.1038/sj.leu.2402376 · Cited by 46
Antiangiogenic treatment with endostatin inhibits progression of AML in vivo
Schuch, G., Oliveira‐Ferrer, L., Loges, S., Laack, E., Bokemeyer, C., HOSSFELD, D. K., Fiedler, W., & Ergün, S. (2005) · Leukemia · doi:10.1038/sj.leu.2403824 · Cited by 42
Lack of Antitumor Activity of Recombinant Endostatin in a Human Neuroblastoma Xenograft Model
Jouanneau, E., Alberti, L., Nejjari, M., Treilleux, I., Vilgrain, I., Duc, A., Combaret, V., Favrot, M., Leboulch, P., & Bachelot, T. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1006420200626 · Cited by 41
Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo
Jin, X., Bookstein, R., Wills, K. N., Avanzini, J. B., Tsai, V., LaFace, D., Terracina, G., Shi, B., & Nielsen, L. L. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700396 · Cited by 39
Subramanian, I. V., Ghebre, R. G., & Ramakrishnan, S. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302352 · Cited by 38
Treatment of Human Pancreatic Cancer in Mice with Angiogenic Inhibitors
Prox, D., Becker, C. M., Pirie-Shepherd, S. R., Celik, I., Folkman, J., & Kisker, O. (2003) · World Journal of Surgery · doi:10.1007/s00268-002-6816-4 · Cited by 38
Self-citationInhibition of Orthotopic Human Bladder Tumor Growth by Lentiviral Gene Transfer of Endostatin
Kikuchi, E., Menéndez, S., Ohori, M., Cordon‐Cardo, C., Kasahara, N., & Bochner, B. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0099 · Cited by 38
Sacco, M. G., Catò, E. M., Ceruti, R., Soldati, S., Indraccolo, S., Caniatti, M., Scanziani, E., & Vezzoni, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301358 · Cited by 37
Beck, M. T., Chen, N. Y., Franek, K. J., & Chen, W. Y. (2003) · PubMed · Cited by 36
Therapeutic Effects of Viral Vector-Mediated Antiangiogenic Gene Transfer in Malignant Ascites
Hampl, M., Tanaka, T., Albert, P. S., Lee, J., Ferrari, N., & Fine, H. A. (2001) · Human Gene Therapy · doi:10.1089/104303401750476221 · Cited by 36
Li, G., Sham, J. S. T., Yang, J., Su, C., Xue, H., Chua, D. T.-T., Lichen, S., Zhang, Q., Cui, Z., Wu, M., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20581 · Cited by 33
Velde, E. A. T., Reijerkerk, A., Brandsma, D., Vogten, J. M., Wu, Y., Kranenburg, O., Voest, E. E., Gebbink, M. F. B. G., & Rinkes, I. H. M. B. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602385 · Cited by 32
Plum, S. M., Hanson, A. D., Völker, K., Vu, H., Sim, B. K. L., Fogler, W. E., & Fortier, A. H. (2003) · PubMed · Cited by 32
Isayeva, T., Ren, C., & Ponnazhagan, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1342.11.3 · Cited by 32
Boehle, A. S., Kurdow, R., Schulze, M., Kliche, U., Sipos, B., Soondrum, K., Ebrahimnejad, A., Dohrmann, P., Kalthoff, H., Henne‐Bruns, D., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1471 · Cited by 31
Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery
Li, L. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i13.1867 · Cited by 31
ABRAHAM, D., ABRI, S., Hofmann, M., HÖLTL, W., & Aharinejad, S. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000075917.98929.57 · Cited by 28
Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine
Wu, Y., Yang, H. H., Hu, B., Liu, J., Su, J., Luo, Y., Ding, Z., Niu, T., Li, Q., Xie, X., et al. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200506000-00011 · Cited by 28
Pulkkanen, K. J., Laukkanen, J. M., Fuxe, J., Kettunen, M. I., Rehn, M., Kannasto, J., Parkkinen, J. J., Kauppinen, R. A., Pettersson, R. F., & Ylä‐Herttuala, S. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700519 · Cited by 26
Nakashima, Y., Yano, M., Kobayashi, Y., Moriyama, S., Sasaki, H., Toyama, T., Yamashita, H., Fukai, I., Iwase, H., Yamakawa, Y., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301856 · Cited by 25
Tai, K., Chen, P., Chen, D., & Hwang, L. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.376 · Cited by 24
Weiss, J. M., Shivakumar, R., Feller, S., Li, L., Hanson, A., Fogler, W. E., Fratantoni, J. C., & Liu, L. N. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700686 · Cited by 22
The Anti-Angiogenic Activity of Human Endostatin Inhibits Bladder Cancer Growth and Its Mechanism
Du, Z., & Hou, S.-K. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000091879.18156.22 · Cited by 22
Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model
Luo, X., Slater, J. M., & Gridley, D. S. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.038 · Cited by 21
Therapy of Hematogenous Melanoma Brain Metastases with Endostatin
Kirsch, M., Weigel, P., Pinzer, T., Carroll, R. S., Black, P. M., Schackert, H. K., & Schackert, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1259.11.3 · Cited by 21
Hong, S.-Y., Lee, M. H., Kim, K., Chung, H. C., Roh, J. K., Hyung, W. J., Noh, S. H., & Choi, S. H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i8.1191 · Cited by 20
Immune Response Against 3LL Lewis Lung Carcinoma Potentiates the Therapeutic Efficacy of Endostatin
Li, M., Huang, X., Zhu, Z.-Y., Wong, M. K. K., Watkins, S. C., Zhao, Q., Herberman, R. B., & Gorelik, E. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00004 · Cited by 20
Inhibition of metastatic brain tumor growth by intramuscular administration of the endostatin gene
Oga, M., Takenaga, K., Satô, Y., Nakajima, H., Koshikawa, N., Osato, K., & Sakiyama, S. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.1.73 · Cited by 19
Starving Tumors of Their Lifeblood
Ezzell, C. (1998) · Scientific American · doi:10.1038/scientificamerican1098-33 · Cited by 19
Cui, R., Takahashi, K., Takahashi, F., Tanabe, K. K., & Fukuchi, Y. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.02.045 · Cited by 19
Mallery, S. R., Morse, M. A., Wilson, R. F., Pei, P., Ness, G. M., Bradburn, J. E., Renner, R. J., Schuller, D. E., & Robertson, F. M. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10489 · Cited by 18
Kałas, W., Gilpin, S. E., Yu, J., May, L. L., Krchnakova, H., BORNSTEIN, P. K., & Rak, J. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.128 · Cited by 18
Steele, F. R. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0574 · Cited by 5
Miyake, K., Inokuchi, K., Miyake, N., Dan, K., & Shimada, T. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302427 · Cited by 5
Yano, M., Nakashima, Y., Kobayashi, Y., Mizuno, K., Konishi, A., Sasaki, H., Fukai, I., Scheule, R. K., & Fujii, Y. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700704 · Cited by 4
Cited by
Angiogenesis: an organizing principle for drug discovery?
Folkman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2115 · Cited by 2,246
Self-citationUlbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
Basement Membranes: Cell Scaffoldings and Signaling Platforms
Yurchenco, P. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004911 · Cited by 959
Biological properties of “naked” metal nanoparticles☆
BHATTACHARYA, R., & MUKHERJEE, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.013 · Cited by 917
Metadata
- Authors
- FOLKMAN, J.
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 2006-03-10
- Volume
- 312
- Issue
- 5
- Pages
- 594-607
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W2075780259
- Cited by
- 658
- References
- 115
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.